Lb Pharmaceuticals reported total assets of $361.69M and total liabilities of $29.34M for the quarter ended Jun 2026. This balance sheet covers 8 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.10M | 0.34M | 0.42M | 0.50M | 0.60M | |||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash & EquivalentsCash & Equiv. | 22.98M | 269.74M | 250.17M | 320.68M | 283.11M | |||
| Prepaid Assets | 0.88M | 1.92M | 13.22M | 23.44M | 27.51M | |||
| Current Assets | 28.88M | 316.40M | 308.43M | 389.07M | 355.30M | |||
| Non-Current Assets | ||||||||
| Property, Plant & Equipment (Net) | 1.86M | 1.64M | 1.58M | 1.53M | 2.20M | |||
| Other Non-Current Assets | 0.50M | 0.51M | 0.77M | 0.78M | 0.78M | |||
| Non-Current Assets | 4.66M | 4.34M | 4.50M | 4.41M | 6.39M | |||
| Assets | 33.53M | 320.75M | 312.93M | 393.48M | 361.69M | |||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payables | 2.32M | 2.59M | 2.13M | 7.12M | 3.49M | |||
| Notes Payables | 2.50M | 0.94M | 1.34M | 1.14M | 1.41M | |||
| Payables | 4.82M | 3.53M | 3.47M | 8.26M | 4.90M | |||
| Accumulated Expenses | 5.30M | 3.33M | 4.58M | 3.06M | 19.23M | |||
| Other Accumulated Expenses | 0.23M | 0.20M | 0.27M | 0.13M | 0.16M | |||
| Current Leases | 0.49M | 0.73M | 0.73M | 0.73M | 0.84M | |||
| Total Current Liabilities | 8.11M | 6.65M | 7.44M | 10.91M | 23.56M | |||
| Non-Current Liabilities | ||||||||
| Pension | 0.80M | 0.87M | 0.52M | 0.26M | 0.80M | |||
| Operating Leases | 3.22M | 2.94M | 2.84M | 2.74M | 4.37M | |||
| Other Non-Current Liabilities | 2.50M | 0.94M | 1.34M | 1.14M | 1.41M | |||
| Total Non-Current Liabilities | 11.32M | 9.58M | 10.28M | 13.65M | 27.94M | |||
| Total Liabilities | 91.45M | 13.83M | 99.34M | 103.87M | 10.53M | 11.62M | 14.79M | 29.34M |
| Shareholder's Equity | ||||||||
| Total Debt | 2.50M | 0.94M | 1.34M | 1.14M | 1.41M | |||
| Common Equity | -91.45M | -94.55M | -99.34M | -103.87M | 310.22M | 301.31M | 378.69M | 332.35M |
| Liabilities and Shareholders Equity | 33.53M | 320.75M | 312.93M | 393.48M | 361.69M | |||
| Retained Earnings | -104.32M | -118.10M | -129.53M | -148.60M | -200.20M | |||
| Preferred Shares | 107.06M | |||||||
| Treasury Shares | 73.82M | 78.07M | 73.82M | 73.82M |